Clinical Trial Update: Stop Infliximab in Patients With Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating stopping infliximab therapy in Crohn's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED